559 related articles for article (PubMed ID: 30666255)
1. IRF4 and IRGs Delineate Clinically Relevant Gene Expression Signatures in Systemic Lupus Erythematosus and Rheumatoid Arthritis.
Rodríguez-Carrio J; López P; Alperi-López M; Caminal-Montero L; Ballina-García FJ; Suárez A
Front Immunol; 2018; 9():3085. PubMed ID: 30666255
[No Abstract] [Full Text] [Related]
2. Heterogeneity of the Type I Interferon Signature in Rheumatoid Arthritis: A Potential Limitation for Its Use As a Clinical Biomarker.
Rodríguez-Carrio J; Alperi-López M; López P; Ballina-García FJ; Suárez A
Front Immunol; 2017; 8():2007. PubMed ID: 29387065
[TBL] [Abstract][Full Text] [Related]
3. IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus.
Zhao M; Zhou Y; Zhu B; Wan M; Jiang T; Tan Q; Liu Y; Jiang J; Luo S; Tan Y; Wu H; Renauer P; Del Mar Ayala Gutiérrez M; Castillo Palma MJ; Ortega Castro R; Fernández-Roldán C; Raya E; Faria R; Carvalho C; Alarcón-Riquelme ME; Xiang Z; Chen J; Li F; Ling G; Zhao H; Liao X; Lin Y; Sawalha AH; Lu Q
Ann Rheum Dis; 2016 Nov; 75(11):1998-2006. PubMed ID: 26787370
[TBL] [Abstract][Full Text] [Related]
4. Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies.
Hua J; Kirou K; Lee C; Crow MK
Arthritis Rheum; 2006 Jun; 54(6):1906-16. PubMed ID: 16736505
[TBL] [Abstract][Full Text] [Related]
5. Randomized, Double-Blind, Placebo-Controlled Trial of the Effect of Vitamin D3 on the Interferon Signature in Patients With Systemic Lupus Erythematosus.
Aranow C; Kamen DL; Dall'Era M; Massarotti EM; Mackay MC; Koumpouras F; Coca A; Chatham WW; Clowse ME; Criscione-Schreiber LG; Callahan S; Goldmuntz EA; Keyes-Elstein L; Oswald M; Gregersen PK; Diamond B
Arthritis Rheumatol; 2015 Jul; 67(7):1848-57. PubMed ID: 25777546
[TBL] [Abstract][Full Text] [Related]
6. Interferon score is increased in incomplete systemic lupus erythematosus and correlates with myxovirus-resistance protein A in blood and skin.
Lambers WM; de Leeuw K; Doornbos-van der Meer B; Diercks GFH; Bootsma H; Westra J
Arthritis Res Ther; 2019 Dec; 21(1):260. PubMed ID: 31791398
[TBL] [Abstract][Full Text] [Related]
7. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
Bodewes ILA; Huijser E; van Helden-Meeuwsen CG; Tas L; Huizinga R; Dalm VASH; van Hagen PM; Groot N; Kamphuis S; van Daele PLA; Versnel MA
J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738
[TBL] [Abstract][Full Text] [Related]
8. A redundant epistatic interaction between IRF5 and STAT4 of the type I interferon pathway in susceptibility to lupus and rheumatoid arthritis.
Kim K; Cho SK; Han TU; Kim JH; Kang SJ; Kang C; Bae SC
Lupus; 2013 Nov; 22(13):1336-40. PubMed ID: 24014567
[TBL] [Abstract][Full Text] [Related]
9. Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus.
Nzeusseu Toukap A; Galant C; Theate I; Maudoux AL; Lories RJ; Houssiau FA; Lauwerys BR
Arthritis Rheum; 2007 May; 56(5):1579-88. PubMed ID: 17469140
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Surrogate Markers of the Type I Interferon Response and Their Ability to Mirror Disease Activity in Systemic Lupus Erythematosus.
Enocsson H; Wetterö J; Eloranta ML; Gullstrand B; Svanberg C; Larsson M; Bengtsson AA; Rönnblom L; Sjöwall C
Front Immunol; 2021; 12():688753. PubMed ID: 34276678
[TBL] [Abstract][Full Text] [Related]
11. A cluster of type II interferon-regulated genes associates with disease activity in patients with systemic lupus erythematosus.
Siddiqi KZ; Zinglersen AH; Iversen KK; Rasmussen NS; Nielsen CT; Jacobsen S
J Autoimmun; 2022 Oct; 132():102869. PubMed ID: 35933792
[TBL] [Abstract][Full Text] [Related]
12. The multifaceted balance of TNF-α and type I/II interferon responses in SLE and RA: how monocytes manage the impact of cytokines.
Smiljanovic B; Grün JR; Biesen R; Schulte-Wrede U; Baumgrass R; Stuhlmüller B; Maslinski W; Hiepe F; Burmester GR; Radbruch A; Häupl T; Grützkau A
J Mol Med (Berl); 2012 Nov; 90(11):1295-309. PubMed ID: 22610275
[TBL] [Abstract][Full Text] [Related]
13. Identification of highly active systemic lupus erythematosus by combined type I interferon and neutrophil gene scores vs classical serologic markers.
Chasset F; Ribi C; Trendelenburg M; Huynh-Do U; Roux-Lombard P; Courvoisier DS; Chizzolini C;
Rheumatology (Oxford); 2020 Nov; 59(11):3468-3478. PubMed ID: 32375176
[TBL] [Abstract][Full Text] [Related]
14. Differentially methylation of IFI44L gene promoter in Iranian patients with systemic lupus erythematosus and rheumatoid arthritis.
Salesi M; Dehabadi MH; Salehi R; Salehi A; Pakzad B
Mol Biol Rep; 2022 Apr; 49(4):3065-3072. PubMed ID: 35059970
[TBL] [Abstract][Full Text] [Related]
15. T cell receptor β repertoires as novel diagnostic markers for systemic lupus erythematosus and rheumatoid arthritis.
Liu X; Zhang W; Zhao M; Fu L; Liu L; Wu J; Luo S; Wang L; Wang Z; Lin L; Liu Y; Wang S; Yang Y; Luo L; Jiang J; Wang X; Tan Y; Li T; Zhu B; Zhao Y; Gao X; Wan Z; Huang C; Fang M; Li Q; Peng H; Liao X; Chen J; Li F; Ling G; Zhao H; Luo H; Xiang Z; Liao J; Liu Y; Yin H; Long H; Wu H; Yang H; Wang J; Lu Q
Ann Rheum Dis; 2019 Aug; 78(8):1070-1078. PubMed ID: 31101603
[TBL] [Abstract][Full Text] [Related]
16. Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients.
Higgs BW; Zhu W; Richman L; Fiorentino DF; Greenberg SA; Jallal B; Yao Y
Int J Rheum Dis; 2012 Feb; 15(1):25-35. PubMed ID: 22324944
[TBL] [Abstract][Full Text] [Related]
17. Importance of correlation between gene expression levels: application to the type I interferon signature in rheumatoid arthritis.
Reynier F; Petit F; Paye M; Turrel-Davin F; Imbert PE; Hot A; Mougin B; Miossec P
PLoS One; 2011; 6(10):e24828. PubMed ID: 22043277
[TBL] [Abstract][Full Text] [Related]
18. Cross-Disease Innate Gene Signature: Emerging Diversity and Abundance in RA Comparing to SLE and SSc.
Petrackova A; Horak P; Radvansky M; Skacelova M; Fillerova R; Kudelka M; Smrzova A; Mrazek F; Kriegova E
J Immunol Res; 2019; 2019():3575803. PubMed ID: 31396542
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for ANA positivity in healthy persons.
Li QZ; Karp DR; Quan J; Branch VK; Zhou J; Lian Y; Chong BF; Wakeland EK; Olsen NJ
Arthritis Res Ther; 2011 Mar; 13(2):R38. PubMed ID: 21366908
[TBL] [Abstract][Full Text] [Related]
20. Genetics of serum concentration of IL-6 and TNFα in systemic lupus erythematosus and rheumatoid arthritis: a candidate gene analysis.
Solus JF; Chung CP; Oeser A; Li C; Rho YH; Bradley KM; Kawai VK; Smith JR; Stein CM
Clin Rheumatol; 2015 Aug; 34(8):1375-82. PubMed ID: 25652333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
